Liver Fibrosis

patient care perspectives by Arun J. Sanyal, MD

Across different health care settings, there is a move to risk stratify patients with nonalcoholic fatty liver disease (NAFLD) using clinical facto......READ MORE

Liver Fibrosis

patient care perspectives by Arun J. Sanyal, MD

Noninvasive testing for nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is an area that is rapidly evolving. In the em......READ MORE

Liver Fibrosis

clinical topic updates by Arun J. Sanyal, MD

The progression of nonalcoholic fatty liver disease (NAFLD) to its fibrotic forms may be associated with the acceleration of other metabolically dr......READ MORE

Liver Fibrosis

clinical topic updates by Raymond Chung, MD

Noninvasive tests for liver fibrosis are becoming increasingly validated in clinical practice and, in many cases, may supplant the performance of l......READ MORE

Liver Fibrosis

clinical topic updates by Raymond Chung, MD

With the rising prevalence of nonalcoholic fatty liver disease, numerous agents are currently being studied in clinical trials as monotherapies for......READ MORE